Drug Description in Trials / DrugBank / KEGG DRUG
Search results
| No. | Drug (Description in trials) | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | Disease ID |
|---|---|---|---|---|---|---|
| 1 | SOC | - | - | - | - | [1] 47 47 |
| 2 | SoC Therapy | - | - | - | - | [1] 171 171 |
| 3 | SoC: cyclophosphamide, bortezomib, and Dexamethasone (CyBorD) | [3] Bortezomib Bortezomib,Cyclophosphamide, Dexamethasone | [4] D00287
D00287
,D00292 , D03150 , D07760 | [2] NR3C1 NR3C1,PSMB5 💬 | [9] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬 | [1] 28 28 |
| 4 | Standard of Care (SoC) | - | - | - | - | [1] 85 85 |